Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03974022 |
|---|---|
| Brief Title: | Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) |
| First Submitted : | May 21, 2019 |
| First Submitted that Met QC Criteria : | June 3, 2019 |
| First Posted : | June 4, 2019 |
| Last Update Submitted that Met QC Criteria : | May 14, 2024 |
| Last Update Posted : | May 15, 2024 (Estimate) |